Adaptive designs, such as multi-arm, multi-stage (MAMS) trials, allow for sustained infrastructure and high throughput of putative DMTs and testing of exploratory outcomes, with a reduced proportion of participants being allocated to placebo [41]
Transparency and Total Costs in GLP-1 Affordability Programs When evaluating Ro Discount or any GLP-1 access program, scrutinize what is included and what is excluded
C., Zanotto, C
Cancer Causes & Control, 28(3), 247258
While improvements in diet and physical activity might explain some of the overall improvement, they do not account for the differences observed between the active and placebo groups
Our advice is to speak to your GP about the risks and benefits of GLP-1 medicines before taking them, and only take those prescribed by a healthcare professional. The authors say that further studies evaluating the impact of these medications on pregnancy and unborn babies are warranted